Hematology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vascular Disease
Derma Sciences Appoints Clinical Advisory Board
April 16th, 2007
Derma Sciences, Inc. (OTCBB: DSCI), a manufacturer and full line supplier of wound and skin care products, announced the formation of a Clinical Advisory Board to help guide the Company's clinical development strategy for its Active Manuka Honey (API-MED(TM)) line of dressings currently under review for 510K clearance, and its MOBILITY-1(TM) Intermittent Pneumatic Compression (IPC) Therapy device. Comprised of US key opinion leaders in wound care, burn care, dermatology and vascular diseases and surgery, the Clinical Advisory Board will play an important role in guiding the upcoming launch of the Active Manuka Honey based product which, if approved, will be the first...
Source: Hematology Week (2007-04-16)
|
